Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 75: 86-92, 1993;
8750-7587/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindeman, K. S.
Right arrow Articles by Freed, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindeman, K. S.
Right arrow Articles by Freed, A. N.

Journal of Applied Physiology, Vol 75, Issue 1 86-92, Copyright © 1993 by American Physiological Society

ARTICLES

Lemakalim attenuates hypocapnia- and dry air-induced bronchoconstriction in canine peripheral airways

K. S. Lindeman and A. N. Freed
Department of Environmental Health Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205.

To determine the effect of changes in potassium (K+) flux on airway constriction, we studied effects of lemakalim, a K+ channel opener, and glibenclamide, an ATP-sensitive K+ channel blocker. A wedged bronchoscope technique was used to measure peripheral airway resistance (Rp) in anesthetized dogs. Rp was measured before and after constriction of the airways by hypocapnic challenge, acetylcholine aerosol, or dry air hyperpnea. Lemakalim (5 micrograms/kg i.v.) was administered, and the challenge was repeated. Lemakalim attenuated responses to hypocapnia by 72 +/- 7% (n = 6, P = 0.0007) and to dry air challenge by 37 +/- 8% (n = 6, P = 0.005) but not to acetylcholine. On separate days, sublobar segments were pretreated with aerosolized glibenclamide (2 mg/ml), and responses to hypocapnic challenge were measured before and after lemakalim (5 micrograms/kg i.v.), nifedipine (20 micrograms/kg i.v.), or albuterol (1 microgram/kg i.v.). In the presence of glibenclamide, lemakalim had no significant effect on responses to hypocapnia; however, both nifedipine (n = 6, P = 0.0003) and albuterol (n = 6, P = 0.0001) attenuated responses to hypocapnic challenge. These findings suggest that lemakalim attenuated hypocapnic bronchoconstriction by promoting K+ efflux through ATP-sensitive K+ channels.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
J. G. LAFFEY, D. ENGELBERTS, and B. P. KAVANAGH
Injurious Effects of Hypocapnic Alkalosis in the Isolated Lung
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 399 - 405.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
O. Bayindir, B. Akpinar, U. Ozbek, E. Cakali, U. Pekcan, F. Bulutcu, and B. Sonmez
The hazardous effects of alveolar hypocapnia on lung mechanics during weaning from cardiopulmonary bypass
Perfusion, January 1, 2000; 15(1): 27 - 31.
[Abstract] [PDF]

Home page
 J. Appl. Physiol.Home page
B. A. Simon, K. Tsuzaki, and J. G. Venegas
Changes in regional lung mechanics and ventilation distribution after unilateral pulmonary artery occlusion
J Appl Physiol, March 1, 1997; 82(3): 882 - 891.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online